Mary Cruz Torrico
Universidad Mayor
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mary Cruz Torrico.
Infection and Immunity | 2000
Johan Vekemans; Carine Truyens; Faustino Torrico; Marco Solano; Mary Cruz Torrico; Patricia Rodriguez; Cristina Alonso-Vega; Yves Carlier
ABSTRACT The possibility of maternal in utero modulation of the innate and/or adaptive immune responses of uninfected newborns fromTrypanosoma cruzi-infected mothers was investigated by studying the capacity of their whole blood cells to produce cytokines in response to T. cruzi lysate or lipopolysaccharide-plus-phytohemagglutinin (LPS-PHA) stimulation. Cells of such newborns occasionally released gamma interferon (IFN-γ) and no interleukin-2 (IL-2) and IL-4 upon specific stimulation, while their mothers responded by the production of IFN-γ, IL-2, and IL-4. Infection in mothers was also associated with a hyperactivation of maternal cells and also, strikingly, of cells of their uninfected neonates, since their release of proinflammatory (IL-1β, IL-6, and tumor necrosis factor alpha [TNF-α]) as well as of anti-inflammatory (IL-10 and soluble TNF receptor) cytokines or factors was upregulated in the presence of LPS-PHA and/or parasite lysate. These results show that T. cruzi infection in mothers induces profound perturbations in the cytokine response of their uninfected neonates. Such maternal influence on neonatal innate immunity might contribute to limit the occurrence and severity of congenital infection.
Tropical Medicine & International Health | 2006
Faustino Torrico; Cristina Alonso Vega; Eduardo Suarez; Tatiana Tellez; Laurent Brutus; Patricia Rodriguez; Mary Cruz Torrico; Dominique Schneider; Carine Truyens; Yves Carlier
Background Comparing two surveys performed in Bolivia in 1992–1994 and 1999–2001, we reported a significant decrease in the proportions of severe and mortal forms of congenital Chagas disease. This might be due to a reduction of vectorial density (VD) in maternal residence area, raising the question of a possible causal relationship between such VD, maternal parasitaemia and prognosis of congenital infection with Trypanosoma cruzi.
PLOS ONE | 2012
Lineth Garcia; Sylvia Ortiz; Gonzalo Osorio; Mary Cruz Torrico; Faustino Torrico; Aldo Solari
The aim of this study was to establish the phylogenetic relationships of trypanosomes present in blood samples of Bolivian Carollia bats. Eighteen cloned stocks were isolated from 115 bats belonging to Carollia perspicillata (Phyllostomidae) from three Amazonian areas of the Chapare Province of Bolivia and studied by xenodiagnosis using the vectors Rhodnius robustus and Triatoma infestans (Trypanosoma cruzi marenkellei) or haemoculture (Trypanosoma dionisii). The PCR DNA amplified was analyzed by nucleotide sequences of maxicircles encoding cytochrome b and by means of the molecular size of hyper variable regions of minicircles. Ten samples were classified as Trypanosoma cruzi marinkellei and 8 samples as Trypanosoma dionisii. The two species have a different molecular size profile with respect to the amplified regions of minicircles and also with respect to Trypanosoma cruzi and Trypanosoma rangeli used for comparative purpose. We conclude the presence of two species of bat trypanosomes in these samples, which can clearly be identified by the methods used in this study. The presence of these trypanosomes in Amazonian bats is discussed.
Molecular Ecology | 2015
Louisa A. Messenger; Lineth Garcia; Mathieu Vanhove; Carlos Huaranca; Marinely Bustamante; Mary Cruz Torrico; Faustino Torrico; Michael A. Miles; Martin S. Llewellyn
An improved understanding of how a parasite species exploits its genetic repertoire to colonize novel hosts and environmental niches is crucial to establish the epidemiological risk associated with emergent pathogenic genotypes. Trypanosoma cruzi, a genetically heterogeneous, multi‐host zoonosis, provides an ideal system to examine the sylvatic diversification of parasitic protozoa. In Bolivia, T. cruzi I, the oldest and most widespread genetic lineage, is pervasive across a range of ecological clines. High‐resolution nuclear (26 loci) and mitochondrial (10 loci) genotyping of 199 contemporaneous sylvatic TcI clones was undertaken to provide insights into the biogeographical basis of T. cruzi evolution. Three distinct sylvatic parasite transmission cycles were identified: one highland population among terrestrial rodent and triatomine species, composed of genetically homogenous strains (Ar = 2.95; PA/L = 0.61; DAS = 0.151), and two highly diverse, parasite assemblages circulating among predominantly arboreal mammals and vectors in the lowlands (Ar = 3.40 and 3.93; PA/L = 1.12 and 0.60; DAS = 0.425 and 0.311, respectively). Very limited gene flow between neighbouring terrestrial highland and arboreal lowland areas (distance ~220 km; FST = 0.42 and 0.35) but strong connectivity between ecologically similar but geographically disparate terrestrial highland ecotopes (distance >465 km; FST = 0.016–0.084) strongly supports ecological host fitting as the predominant mechanism of parasite diversification. Dissimilar heterozygosity estimates (excess in highlands, deficit in lowlands) and mitochondrial introgression among lowland strains may indicate fundamental differences in mating strategies between populations. Finally, accelerated parasite dissemination between densely populated, highland areas, compared to uninhabited lowland foci, likely reflects passive, long‐range anthroponotic dispersal. The impact of humans on the risk of epizootic Chagas disease transmission in Bolivia is discussed.
American Journal of Tropical Medicine and Hygiene | 2009
Faustino Torrico; Rudy Parrado; Rosario Castro; Carla Jimena Marquez; Mary Cruz Torrico; Marco Solano; Richard Reithinger; Ana Lineth Garcia
We describe the first case of Leishmania/HIV co-infection reported in Bolivia. Initially hospitalized with a diagnosis of pneumonia and bronchitis, the patient had numerous cutaneous and mucosal lesions caused by Leishmania (Viannia) braziliensis. The patient was also diagnosed as severely immunocompromised because of HIV infection.
Veterinary Parasitology | 2011
Rudy Parrado; Ernesto Rojas; Raúl Delgado; Mary Cruz Torrico; Richard Reithinger; Ana Lineth Garcia
Data on Leishmania spp. infection in dogs in Bolivia is scarce. Dogs from an area where 90% of human cutaneous leishmaniasis (CL) cases are due to Leishmania (Viannia) braziliensis were screened for Leishmania infection using established enzyme-linked immunosorbent antibody test (ELISA) protocols. Although none of the 51 dogs surveyed had clinical lesions indicative of CL, 6 out of 51 (11.8%) sampled dogs tested positive by ELISA.
Food & Nutrition Research | 2014
Miguel Guzman-Rivero; Ernesto Rojas; Aleida Verduguez-Orellana; Henry Pardo; Mary Cruz Torrico; Lieselotte Cloetens; Björn Åkesson; Edgar Sejas
Background The role of micronutrient status for the incidence and clinical course of cutaneous leishmaniasis is not much studied. Still zinc supplementation in leishmaniasis has shown some effect on the clinical recovery, but the evidence in humans is limited. Objective To compare biochemical nutritional status in cutaneous leishmaniasis patients with that in controls and to study the effects of zinc supplementation for 60 days. Design Twenty-nine patients with cutaneous leishmaniasis were treated with antimony for 20 days. Fourteen of them got 45 mg zinc daily and 15 of them got placebo. Biomarkers of nutritional and inflammatory status and changes in size and characteristics of skin lesions were measured. Results The level of transferrin receptor was higher in patients than in controls but otherwise no differences in nutritional status were found between patients and controls. No significant effects of zinc supplementation on the clinical recovery were observed as assessed by lesion area reduction and characteristics or on biochemical parameters. Conclusions It is concluded that nutritional status was essentially unaffected in cutaneous leishmaniasis and that oral zinc supplementation administered together with intramuscular injection of antimony had no additional clinical benefit.
Journal of Clinical Microbiology | 2008
Rudy Parrado; Daniel Lozano; Lineth Garcia; Mary Cruz Torrico; Raúl Delgado; Faustino Torrico; Monica Laserna; Richard Reithinger
Bolivia has one of the highest incidence rates of tuberculosis (TB) in the Americas. An estimated 15,000 new cases per year are detected ([1][1]), which corresponds to an incidence rate of 112 cases per 100,000 population; 1,600 deaths due to TB are reported to occur annually ([10][2]). The actual
American Journal of Tropical Medicine and Hygiene | 2004
Faustino Torrico; Cristina Alonso-Vega; Eduardo Suarez; Patricia Rodriguez; Mary Cruz Torrico; Michèle Dramaix; Carine Truyens; Yves Carlier
Revista Da Sociedade Brasileira De Medicina Tropical | 2005
Mary Cruz Torrico; Marco Solano; Guzmán Jm; Parrado R; Eduardo Suarez; Alonzo-Vega C; Carine Truyens; Yves Carlier; Faustino Torrico